Kyntra Bio Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Kyntra Bio stock has a consensus rating of "Buy" and an average price target of $39. The average 1-year stock price forecast is 432.79% higher than the current stock price, while the lowest is $35 (+378.14%) and the highest is $43 (+487.43%).

Price Target: $39 (+432.79%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$35	$39	$39	$43
Change	+378.14%	+432.79%	+432.79%	+487.43%

Analyst Ratings

The average analyst rating for Kyntra Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Feb '26	Mar '26	May '26	Jul '26
Strong Buy	0	1	1	1	1	2
Buy	1	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jay Olson Oppenheimer	Oppenheimer	Buy Initiates $35	Buy	Initiates	$35	+378.14%	Jul 6, 2026
Michael King Rodman & Renshaw	Rodman & Renshaw	Buy Initiates $30	Buy	Initiates	$30	+309.84%	Jun 9, 2026
Matthew Keller H.C. Wainwright	H.C. Wainwright	Buy Reiterates $43	Buy	Reiterates	$43	+487.43%	May 12, 2026
Andy Hsieh William Blair	William Blair	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 12, 2026

Financial Forecast

Revenue This Year

7.95M

from 6.44M

23.45%

from 6.44M

Revenue Next Year

6.70M

from 7.95M

-15.72%

from 7.95M

EPS This Year

-13.89

from 45.37

EPS Next Year

-9.73

from -13.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	235.31M	140.73M	46.80M	29.62M	6.44M	7.95M
Revenue Growth	33.46%	-40.19%	-66.74%	-36.71%	-78.26%	23.45%
Operating Income	-348.53M	-301.03M	-334.75M	-130.96M	-45.34M	-52.75M
Net Income	-290.02M	-293.65M	-284.23M	-47.58M	183.45M	-57.25M
EPS	-	-	-	-	45.37	-13.89
Free Cash Flow	-98.14M	-104.83M	-273.99M	-150.77M	5.11M	-18.20M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	8.4M
Avg	8.0M
Low	7.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	30.4%
Avg	23.4%
Low	16.5%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-13.89
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-